By Professor Susan Jane Connor

Journal articles

Cosier D; Lambert K; Charlton K; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg DA; Houshyar Y; Jayawardana T; Koentgen S; Hold GL, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349

Kanazaki R; Smith B; Bu S; Girgis A; Connor SJ, 2024, 'Is the European Crohn’s and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists’ guideline adherence? A mixed methods evaluation', BMC Medical Education, 24, http://dx.doi.org/10.1186/s12909-024-05540-w

Jacob R; Chu V; Ng W; Williams AJ; Connor S, 2024, 'Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience', Internal Medicine Journal, 54, pp. 2009 - 2014, http://dx.doi.org/10.1111/imj.16545

Pierre N; Huynh-Thu VA; Baiwir D; Mazzucchelli G; Fléron M; Trzpiot L; Eppe G; De Pauw E; Laharie D; Satsangi J; Bossuyt P; Vuitton L; Vieujean S; Colombel JF; Meuwis MA; Louis E; Dupas JL; Reimund JM; Bouhnik Y; Jouet P; De Vos M; Belaiche J; Vernier-Massouille G; Nancey S; Grimaud JC; Veyrac M; Boureille A; Flamant M; Jian R; Marteau P; Lemann M; Allez M; Savoye G; Duclos B; Picon L; Andrews A; Sparrow M; Leong R; Connor S; Radforth-Smith G; De Cruz P; Baert F; Louis E; Bossuyt P; Resche-Rignon M; Ding N; Almer S; Ben-Horin S; Siegmund B; Preiss J; Stallmach A; Liceni T; Grip O; Halfvarson J; Durai D; Cummings F; Seilinger C; Parkes M; Lindsay J; Lambrecht G; VanHootegem P; Rahier JF; Dewitte M; Hebuterne X; Chanteloup E; Altwegg R; Bouguen G; de Chambrun GP; Pollenot F; Nachury M; Fumery M; Gilletta C; Viennot S; Roblin X; Irving P; Lamb C; Pollok R; D'Haens G; Hertervig E; Halfvarsson J, 2024, 'External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab', Gut, 73, pp. 1965 - 1973, http://dx.doi.org/10.1136/gutjnl-2024-332648

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5, http://dx.doi.org/10.1016/j.cgh.2024.04.019

Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams AJ; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318

Little RD; McKenzie J; Srinivasan A; Hilley P; Gilmore RB; Chee D; Sandhu M; Saitta D; Chow E; Thin L; Walker GJ; Moore GT; Lynch K; Andrews J; An YK; Bryant RV; Connor SJ; Garg M; Wright EK; Hold G; Segal JP; Boussioutas A; De Cruz P; Ward MG; Sparrow MP, 2024, 'Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081787

De Gregorio M; Sidhu A; Behrenbruch C; Connor SJ; Guerra G; Johnston MJ; Keck JO; Ong EJSK; Thompson AJ; Woods R; D'Souza B; Ding NS, 2024, 'Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand', ANZ Journal of Surgery, 94, pp. 14 - 16, http://dx.doi.org/10.1111/ans.18640

Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1809 - i1809, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135

Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1820 - i1820, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142

Pipicella JL; Wilson W; Ghaly S; Antoniades S; Kate L; Grafton R; Ng W; Sechi A; Somes K; Arnold K; Connor SJ; Andrews JM, 2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1849 - i1850, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1160

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2010 - i2010, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1259

Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i650 - i650, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0416

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i923 - i923, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0592

Pipicella JL; Gu B; Palmer L; Connor SJ; Wilson W; Andrews JM, 2024, 'P529 Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1035 - i1037, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0659

De Gregorio M; Winata LS; Hartley I; Behrenbruch CC; Connor SJ; D‘Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJS; Schulberg JD; Srinivasan A; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2024, 'P547 Improved clinical and radiologic healing of Crohn’s perianal fistulas using a novel coordinated care model optimising medical and surgical treatments: A prospective real-world observational study', Journal of Crohn's and Colitis, 18, pp. i1070 - i1071, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0677

Gu B; Pipicella JL; Palmer L; Connor SJ; Wilson W; Andrews JM, 2024, 'P654 Assessing patient-perceived burden of disease in Ulcerative Colitis: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1236 - i1238, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0784

Khoo E; Amiss A; Ding JN; Bryant R; Mohsen W; Connor S; Leung R; Croft A; Lynch K; Sparrow M; De Cruz P; An YK; Holtmann G; Begun J, 2024, 'P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis', Journal of Crohn's and Colitis, 18, pp. i1573 - i1573, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0984

Pipicella JL; McNamara J; Wilson W; Lynch K; Walker G; Begun J; Lawrance I; Ghaly S; Radford-Smith G; Williams AJ; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1612 - i1613, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1010

Pipicella JL; Dutt S; Giles E; Day AS; Wright R; Goodfellow T; William W; Andrews JM; Connor SJ, 2024, 'P940 A glance into paediatric Inflammatory Bowel Disease in Australasia – Crohn’s Colitis Cure (CCC) data insights program', Journal of Crohn's and Colitis, 18, pp. i1701 - i1702, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1070

Mcnamara J; Alshiwanna B; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JA; Connor SJ, 2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1732 - i1732, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1089

Little RD; Jayawardana T; Koentgen S; Zhang F; Connor SJ; Boussioutas A; Ward MG; Gibson PR; Sparrow MP; Hold GL, 2024, 'Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: Advances and future directions', Egastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100006

Khoo E; Amiss A; Ding NS; Bryant RV; Mohsen W; Connor SJ; Leong R; Croft A; Lynch KD; Sparrow M; De Cruz P; An Y-K; Holtmann GJ; Begun J, 2024, '903 TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)00988-0

Lim E; Thai M; An Y-K; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; Thin L; Sparrow M; Gilmore R; Taylor K; Sallis O; Andrews JM; Daker C; Gearry RB; Wark G; Ghaly S; Begun M; Krishnaprasad K; Wu T; Ruddick-Collins L; Schreiber V; Okano S; Radford-Smith G; Schulberg J; van Langenberg D; Begun J, 2024, 'High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease', GastroHep, 2024, http://dx.doi.org/10.1155/2024/3686618

De Gregorio M; Winata LS-H; Hartley I; Behrenbruch CC; Connor SJ; D'Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJ; Schulberg JD; Srinivasan A; Sutherland T; Woods R; Wright EK; Connell W; Thompson A; Ding NS, 2024, 'Mo1817 IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S PERIANAL FISTULAS USING A NOVEL COORDINATED CARE MODEL OPTIMISING MEDICAL AND SURGICAL TREATMENTS: A PROSPECTIVE REAL-WORLD OBSERVATIONAL STUDY', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03056-7

Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03072-5

McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03073-7

Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03074-9

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 839, http://dx.doi.org/10.1016/s0016-5085(24)02405-3

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)02438-7

Gu B; Pipicella JL; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'Tu1865 ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', Gastroenterology, 166, pp. S - 1444, http://dx.doi.org/10.1016/s0016-5085(24)03766-1

Pipicella JL; Gu B; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'Tu1866 ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN CROHN'S DISEASE: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03767-3

Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03792-2

Pipicella JL; Vernon-Roberts A; Dutt S; Giles E; Day AS; Connor SJ; Andrews JM, 2023, 'Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 4368 - 4380, http://dx.doi.org/10.1007/s10620-023-08146-2

McNamara J; Connor SJ; Andrews JM, 2023, 'The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform', Inflammatory Bowel Diseases, 29, pp. 1510 - 1511, http://dx.doi.org/10.1093/ibd/izad148

Karimi N; Lukin A; Moore AR; Pipicella JL; Kanazaki R; Williams AJ; Ng W; Kariyawasam V; Mitrev N; Pandya K; Connor SJ, 2023, 'Adolescents and young adults communicating with gastroenterologists: Variation in inflammatory bowel disease clinical communication', International Journal of Adolescent Medicine and Health, 35, pp. 347 - 361, http://dx.doi.org/10.1515/ijamh-2023-0078

Kanazaki R; Smith B; Girgis A; Connor SJ, 2023, 'Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers', Crohn S and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otac018

Karimi N; Moore AR; Lukin A; Connor SJ, 2023, 'Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review', Crohn S and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otad021

Chan P; Connor S; Huang V; Karimi N; Williams AJ, 2023, 'Letter: expanding the role for decision aids in IBD into pregnancy-related topics', Alimentary Pharmacology and Therapeutics, 58, pp. 141 - 142, http://dx.doi.org/10.1111/apt.17545

Barnes A; Ooi SYJ; Lynch KD; Parthasarathy N; Bishara M; Gounder M; Grafton R; Leach P; Bampton P; Sechi A; Ng W; Connor S; van Langenberg D; Mountifield R; Andrews JM, 2023, 'Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 889 - 896, http://dx.doi.org/10.1007/s10620-022-07556-y

Louis E; Resche-Rigon M; Laharie D; Satsangi J; Ding N; Siegmund B; D'Haens G; Picon L; Bossuyt P; Vuitton L; Irving P; Viennot S; Lamb CA; Pollok R; Baert F; Nachury M; Fumery M; Gilletta C; Almer S; Ben-Horin S; Bouhnik Y; Colombel JF; Hertervig E; Andrews J; Sparrow M; Leong R; Connor S; Radforth-Smith G; De Cruz P; Preiss J; Stallmach A; Liceni T; Grip O; Halfvarson J; Durai D; Cummings F; Seilinger C; Parkes M; Lindsay J; Lambrecht G; Van Hootegem P; Rahier JF; Dewitte M; Hebuterne X; Chanteloup E; Altwegg R; Nancey S; Bouguen G; Pineton de Chambrun G; Poullenot F; Roblin X, 2023, 'Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial', Lancet Gastroenterology and Hepatology, 8, pp. 215 - 227, http://dx.doi.org/10.1016/S2468-1253(22)00385-5

Mortlock S; Lord A; Montgomery G; Zakrzewski M; Simms LA; Krishnaprasad K; Hanigan K; Doecke JD; Walsh A; Lawrance IC; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow MP; Bell S; Florin TH; Begun J; Gearry RB; Radford-Smith GL, 2023, 'An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis', Journal of Crohn S and Colitis, 17, pp. 277 - 288, http://dx.doi.org/10.1093/ecco-jcc/jjac121

Mah C; Jayawardana T; Leong G; Koentgen S; Lemberg D; Connor SJ; Rokkas T; Grimm MC; Leach ST; Hold GL, 2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12, http://dx.doi.org/10.3390/pathogens12020262

Chan PPY; Farzin M; Acharya P; Viiala N; Gilmore A; Crane H; Henderson C; Ng W; Williams A; Connor SJ, 2023, 'Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis', ACG CASE REPORTS JOURNAL, 10, http://dx.doi.org/10.14309/crj.0000000000000978

Van Oostrom J; Anjie S; Braad M; Horrigan J; Karimi N; Adi B; Ganesh G; Yang SK; Lasa J; Broër C; de Kruif A; Olivera Sendra P; Ye BD; Banerjee R; Connor S; Siegel C; Peyrin-Biroulet L; Gecse K; D’Haens G, 2023, 'P185 Global perception of normal life by healthcare professionals and IBD patients: mind the gap', Journal of Crohn's and Colitis, 17, pp. i337 - i339, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0315

Akyüz F; An YK; Aniwan S; Bui HH; Chan WP; Choi CH; Chopdat N; Connor S; Desai D; Flanagan E; Kobayashi T; Leong RW; Leow A; Leung WK; Limsrivilai J; Peddi K; Pribadi RR; Ran Z; Wei SC; Wu K; Ye BD, 2023, 'P340 Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition', Journal of Crohn's and Colitis, 17, pp. i476 - i478, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0470

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', Journal of Crohn's and Colitis, 17, pp. i542 - i543, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0543

Cheema M; Narouz I; Pipicella J; Garden F; Lynch K; Andrews J; Ghaly S; Connor S, 2023, 'P523 Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn’s Colitis Care (CCCare): A real world observational study.', Journal of Crohn's and Colitis, 17, pp. i650 - i651, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0653

De Gregorio M; D’Souza B; Connell W; Kamm MA; Woods R; Connor SJ; Thompson AJ; Ding NS, 2023, 'P538 Suboptimal disease control is common in patients with Crohn’s perianal fistulas with capacity to optimise medical and surgical treatment in real-world experience: A cross-sectional analysis of baseline disease characteristics in the FINESS study', Journal of Crohn's and Colitis, 17, pp. i666 - i666, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0668

Taxonera C; Ha C; del Pilar Fortes M; Gardiner S; Mundayat R; Ghosh S; Connor SJ, 2023, 'P550 Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years', Journal of Crohn's and Colitis, 17, pp. i678 - i680, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0680

Back to profile page